Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Antiplatelet effects and pharmacodynamics of clopidogrel in cats.

Hogan DF, Andrews DA, Green HW, Talbott KK, Ward MP, Calloway BM.

J Am Vet Med Assoc. 2004 Nov 1;225(9):1406-11.

PMID:
15552317
2.

Evaluation of antiplatelet effects of ticlopidine in cats.

Hogan DF, Andrews DA, Talbott KK, Green HW, Ward MP, Calloway BM.

Am J Vet Res. 2004 Mar;65(3):327-32.

PMID:
15027681
3.

Single-dose pharmacodynamics of clopidogrel.

Thebault JJ, Kieffer G, Cariou R.

Semin Thromb Hemost. 1999;25 Suppl 2:3-8.

PMID:
10440415
4.

Clopidogrel does not affect the pharmacokinetics of theophylline.

Caplain H, Thebault JJ, Necciari J.

Semin Thromb Hemost. 1999;25 Suppl 2:65-8.

PMID:
10440427
5.

Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.

Niitsu Y, Sugidachi A, Ogawa T, Jakubowski JA, Hashimoto M, Isobe T, Otsuguro K, Asai F.

Eur J Pharmacol. 2008 Jan 28;579(1-3):276-82.

PMID:
17996866
6.

Repeated-dose pharmacodynamics of clopidogrel in healthy subjects.

Thebault JJ, Kieffer G, Lowe GD, Nimmo WS, Cariou R.

Semin Thromb Hemost. 1999;25 Suppl 2:9-14.

PMID:
10440416
7.

The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.

Dallob A, Luo WL, Luk JM, Ratcliffe L, Johnson-Levonas AO, Schwartz JI, Dishy V, Kraft WK, De Hoon JN, Van Hecken A, De Lepeleire I, Radziszewski W, Wagner JA, Lai E.

Platelets. 2011;22(7):495-503. doi: 10.3109/09537104.2011.565433.

PMID:
21526889
8.
9.

Clopidogrel induces an acute hemostatic deficit and increases intra abdominal bleeding in rabbits.

Lortie E, Girard F, Boudreault D, Ruel M, Mansour S, Blais N, Hardy JF.

Thromb Res. 2009 Apr;123(6):869-73. doi: 10.1016/j.thromres.2008.10.014.

PMID:
19128824
10.

Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs.

Brainard BM, Kleine SA, Papich MG, Budsberg SC.

Am J Vet Res. 2010 Jul;71(7):822-30. doi: 10.2460/ajvr.71.7.822.

PMID:
20594086
11.

Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis.

Denninger MH, Necciari J, Serre-Lacroix E, Sissmann J.

Semin Thromb Hemost. 1999;25 Suppl 2:41-5.

PMID:
10440422
12.

Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.

Kim SD, Kang W, Lee HW, Park DJ, Ahn JH, Kim MJ, Kim EY, Kim SW, Nam HS, Na HJ, Yoon YR.

Clin Ther. 2009 Apr;31(4):793-803. doi: 10.1016/j.clinthera.2009.04.017.

PMID:
19446152
13.

The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite.

Sugidachi A, Ogawa T, Kurihara A, Hagihara K, Jakubowski JA, Hashimoto M, Niitsu Y, Asai F.

J Thromb Haemost. 2007 Jul;5(7):1545-51. Erratum in: J Thromb Haemost. 2007 Sep;5(9):1995.

14.

Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.

Matetzky S, Fefer P, Shenkman B, Varon D, Savion N, Hod H.

Am J Cardiol. 2008 Sep 1;102(5):524-9. doi: 10.1016/j.amjcard.2008.04.028.

PMID:
18721506
15.

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.

Eikelboom JW, Hankey GJ, Thom J, Claxton A, Yi Q, Gilmore G, Staton J, Barden A, Norman PE.

J Thromb Haemost. 2005 Dec;3(12):2649-55.

17.

Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study.

Neubauer H, Krüger JC, Lask S, Endres HG, Pepinghege F, Engelhardt A, Bulut D, Mügge A.

Clin Res Cardiol. 2009 Sep;98(9):533-40. doi: 10.1007/s00392-009-0033-1.

PMID:
19504141
18.

Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.

Wang J, Albertson CM, Zheng H, Fink LM, Herbert JM, Hauer-Jensen M.

Thromb Haemost. 2002 Jan;87(1):122-8.

PMID:
11848440
20.

Normalization of platelet reactivity in clopidogrel-treated subjects.

Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ.

J Thromb Haemost. 2007 Jan;5(1):82-90.

Items per page

Supplemental Content

Support Center